© John Wiley & Sons Ltd
Editors-in-Chief: David Morgan, Thomas Permutt and Gerd Rosenkranz
Impact Factor: 0.833
ISI Journal Citation Reports © Ranking: 2014: 65/122 (Statistics & Probability); 223/255 (Pharmacology & Pharmacy)
Online ISSN: 1539-1612
Welcome to the new Editor-in-Chief
We are delighted to welcome David Morgan as one of three Editors-in-Chief of Pharmaceutical Statistics.
David Morgan is a seasoned drug development professional with experience in UK, US, German and French pharmaceutical companies. He has degrees in Mathematics and in Applied Statistics from Oxford University and is a Chartered Mathematician and Chartered Statistician. David was Chairman of PSI (Statisticians in the Pharmaceutical Industry) from 1995 to 1997 and President of EFSPI (European Federation of Statisticians in the Pharmaceutical Industry) from 2001 to 2003.
David joins existing editors Thomas Permutt and Gerd Rosenkranz in the role.
Recently Published Articles
- Testing treatment effect in schizophrenia clinical trials with heavy patient dropout using latent class growth mixture models
Fanhui Kong and Yeh-Fong Chen
Version of Record online: 12 MAY 2016 | DOI: 10.1002/pst.1750
- You have full text access to this OnlineOpen article
- Using Bayesian analysis in repeated preclinical in vivo studies for a more effective use of animals (pages 277–285)
Rosalind Walley, John Sherington, Joe Rastrick, Eric Detrait, Etienne Hanon and Gillian Watt
Version of Record online: 29 MAR 2016 | DOI: 10.1002/pst.1748
- Sensitivity to censored-at-random assumption in the analysis of time-to-event endpoints (pages 216–229)
Ilya Lipkovich, Bohdana Ratitch and Michael O'Kelly
Version of Record online: 21 MAR 2016 | DOI: 10.1002/pst.1738